What is McKesson's cash & equivalents?

McKesson (MCK) reported cash & equivalents of $3.98B in Q1 2026.

How has McKesson's cash & equivalents changed year-over-year?

McKesson's cash & equivalents decreased by 33.3% year-over-year, from $5.96B to $3.98B.

What is the long-term trend for McKesson's cash & equivalents?

Over 5 years (2021 to 2026), McKesson's cash & equivalents has grown at a -9.1% compound annual growth rate (CAGR), from $6.4B to $3.98B.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

McKesson MCK Cash & Equivalents

Cash & Equivalents at other companies

Eli LillyLLY

$5.28B+70.8%

Cardinal HealthCAH

$3.94B+18.4%

CencoraCOR

$2.18B+10.0%

AbbVieABBV

$9.39B+81.5%

Amneal Pharmaceuticals, Inc.AMRX

$197.66M+234%

ViatrisVTRS

$1.81B+139%

Other financials

Income statement

See full

Revenue$96.3B+6.0%

Gross profit$4.0B+11.1%

Operating income$2.2B+35.1%

Net income$1.7B+33.5%

EPS (diluted)$13.65+37.6%

Balance sheet

See full

Total debt$2.3B-74.2%

Total equity-$2.2B-4.7%

Total assets$82.3B+9.6%

Cash flow

See full

Operating cash flow$3.4B-55.8%

CapEx$111.0M-34.3%

Free cash flow$3.3B-56.3%

Valuation

See full

Market cap$98.45B+11.6%

Enterprise value$96.75B0.0%

P/E20.7×-7.2×

P/S0.2×0.0×

Profitability

See full

Gross margin3.6%-0.1pp

Operating margin1.5%+0.3pp

Net margin1.2%+0.3pp

FCF margin1.4%-0.1pp

Returns & leverage

See full

Return on equity36%—

Debt / equity2×—

Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: McKesson’s 10-K, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is McKesson's cash & equivalents?: McKesson (MCK) reported cash & equivalents of $3.98B in Q1 2026.
How has McKesson's cash & equivalents changed year-over-year?: McKesson's cash & equivalents decreased by 33.3% year-over-year, from $5.96B to $3.98B.
What is the long-term trend for McKesson's cash & equivalents?: Over 5 years (2021 to 2026), McKesson's cash & equivalents has grown at a -9.1% compound annual growth rate (CAGR), from $6.4B to $3.98B.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.